aod 9604 with tirzepatide AOD-9604 10mg 💉✨ AOD-9604 + 1 Month

Appetite & caloric intake regulation GLP-1 and GIP signaling supports satiety and reduced energy intake

Week 17 onward: 2.4 mg once weekly (maintenance dose)

Many patients experience overlapping gastrointestinal effects in the first 24 weeks, but these typically resolve as your body adapts

[78] revealed that 2550 g/mL Am-EVs in an LPS-induced Caco-2 inflammation model precisely modulated the MAPK signaling cascade through coordinated downregulation of TRIF/MyD88/p38 MAPK/FOS and upregulation of TGFBR2, leading to marked reductions in oxidative stress markers (ROS, MDA), restored catalase activity, and suppressed pro-inflammatory cytokine (TNF-/IL-1/IL-6) expression

Our brand is built on being empathetic, innovative, trustworthy, and supportive, recognizing that true progress comes from a partnership with your health